{"id":202135,"date":"2026-07-02T19:29:08","date_gmt":"2026-07-02T19:29:08","guid":{"rendered":"https:\/\/www.europesays.com\/ch-fr\/202135\/"},"modified":"2026-07-02T19:29:08","modified_gmt":"2026-07-02T19:29:08","slug":"percee-historique-un-nouveau-traitement-contre-le-cancer-du-pancreas-decouvert-98-5-montreal","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch-fr\/202135\/","title":{"rendered":"Perc\u00e9e historique | Un nouveau traitement contre le cancer du pancr\u00e9as d\u00e9couvert \u2014 98.5 Montr\u00e9al"},"content":{"rendered":"<p>Dans le cadre de sa chronique, Marie-Claude Lortie nous fait part d&rsquo;une bonne dose d&rsquo;optimisme en mettant en lumi\u00e8re une perc\u00e9e m\u00e9dicale historique d\u00e9voil\u00e9e au congr\u00e8s de la Soci\u00e9t\u00e9 am\u00e9ricaine d\u2019oncologie clinique \u00e0 Chicago. <\/p>\n<p>Un nouveau traitement exp\u00e9rimental qui utilise le \u00ab daraxonrasib \u00bb, un inhibiteur de prot\u00e9ines, a d\u00e9montr\u00e9 sa capacit\u00e9 \u00e0 doubler le taux de survie chez des patients atteints du cancer du pancr\u00e9as, l&rsquo;un des plus redoutables et difficiles \u00e0 traiter.\u00a0<\/p>\n<p>Test\u00e9 lors d&rsquo;essais cliniques rigoureux men\u00e9s sur 500 patients, ce traitement r\u00e9volutionnaire s&rsquo;accompagne d&rsquo;autres recherches fort prometteuses touchant l&rsquo;immunoth\u00e9rapie et le d\u00e9veloppement de vaccins contre le cancer.<\/p>\n<p>\u00c9coutez la chroniqueuse Marie-Claude Lortie aborder le sujet, jeudi, \u00e0 l&rsquo;\u00e9mission du Midi.<\/p>\n","protected":false},"excerpt":{"rendered":"Dans le cadre de sa chronique, Marie-Claude Lortie nous fait part d&rsquo;une bonne dose d&rsquo;optimisme en mettant en&hellip;\n","protected":false},"author":2,"featured_media":202136,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[9],"tags":[14312,83,84,23],"class_list":["post-202135","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sante","tag-art-de-vivre","tag-health","tag-sante","tag-suisse"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch_fr\/116852042284631673","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/posts\/202135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/comments?post=202135"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/posts\/202135\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/media\/202136"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/media?parent=202135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/categories?post=202135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/tags?post=202135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}